News

The Munich Eye3h
Potential of GLP-1 Therapies in Treating Bardet-Biedl Syndrome Uncovered
Munich news, health insurance, technology, jobs and other topics for expatriates. The Eye Newspapers covers daily news and offers services for foreigners.
GLP-1 therapies show potential for treating rare genetic disorder Bardet-Biedl syndrome
A Monell Chemical Senses Center study published this week in the Journal of Clinical Investigation offers renewed hope for ...
Mirage News19h
GLP-1 Therapies Eyed for Treating Bardet-Biedl Syndrome
A Monell Chemical Senses Center study published this week in the Journal of Clinical Investigation offers renewed hope for individuals living with ...
Clinical Advisor21h
GLP-1 RAs, SGLT2 Inhibitors May Reduce Risk for Alzheimer Disease, Dementia in T2DM
Both GLP-1 receptor agonists and SGLT2 inhibitors linked to reduced risk for ADRD, with no significant difference between them.
Neuroscience News21h
Potential Depression Risk Linked to Ozempic-Like Drugs
A new international study reveals a possible connection between GLP1 receptor agonists—used in drugs like Ozempic—and ...